BHWM
FLGT icon

Beaird Harris Wealth Management’s Fulgent Genetics FLGT Stock Holding History

Beaird Harris Wealth Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15
Closed -$326 – 745
2024
Q1 		$326 Hold
15
– – ﹤0.01% 605
2023
Q4 		$434 Hold
15
– – ﹤0.01% 574
2023
Q3 		$402 Hold
15
– – ﹤0.01% 420
2023
Q2 		$556 Hold
15
– – ﹤0.01% 423
2023
Q1 		$469 Hold
15
– – ﹤0.01% 444
2022
Q4 		$447 Sell
15
-10
-40% -$358 ﹤0.01% 704
2022
Q3 		$1K Buy
+25
New +$1.25K ﹤0.01% 433
2022
Q2 		– Sell
-50
Closed -$3K – 479
2022
Q1 		$3K Buy
+50
New +$3.29K ﹤0.01% 485

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Beaird Harris Wealth Management's FLGT Position: Q2 2024 in Review

Beaird Harris Wealth Management sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 15 shares — an estimated $326 sold.

Beaird Harris Wealth Management first reported a position in FLGT in Q1 2022 and held it in 8 quarters. The position peaked at $3K in Q1 2022. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.

  • Beaird Harris Wealth Management reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
  • Beaird Harris Wealth Management sold 15 Fulgent Genetics shares in Q2 2024, an estimated $326.
  • Beaird Harris Wealth Management first reported a position in Fulgent Genetics in Q1 2022 and held it in 8 quarters.
  • Beaird Harris Wealth Management's Fulgent Genetics position peaked at $3K in Q1 2022.
  • 173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.

Based on Beaird Harris Wealth Management's 13F filing for Q2 2024, filed 15 Aug 2024.